8,362 Shares of Danaher Corporation $DHR Bought by Ables Iannone Moore & Associates Inc.

Ables Iannone Moore & Associates Inc. bought a new position in shares of Danaher Corporation (NYSE:DHR – Free Report) during the third quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor bought 8,362 shares of the conglomerate’s stock, valued at approximately $1,853,000. Danaher makes up 1.0% of Ables Iannone Moore & Associates Inc.’s investment portfolio, making the stock its 20th largest holding.

Other hedge funds and other institutional investors also recently made changes to their positions in the company. BlackRock Inc. bought a new position in Danaher in the 2nd quarter valued at approximately $10,492,520,000. State Street Corp grew its stake in shares of Danaher by 1.7% during the fourth quarter. State Street Corp now owns 27,681,334 shares of the conglomerate’s stock worth $6,345,529,000 after buying an additional 472,608 shares during the last quarter. Wellington Management Group LLP increased its holdings in shares of Danaher by 10.4% during the second quarter. Wellington Management Group LLP now owns 16,316,834 shares of the conglomerate’s stock worth $3,108,031,000 after buying an additional 1,542,310 shares in the last quarter. Jupiter Topco LLC bought a new position in shares of Danaher in the 2nd quarter valued at $1,456,317,000. Finally, Generation Investment Management LLP acquired a new stake in shares of Danaher during the 2nd quarter valued at $1,287,949,000. 79.05% of the stock is currently owned by institutional investors and hedge funds.

Analyst Ratings Changes

A number of equities analysts have issued reports on the company. Piper Sandler initiated coverage on Danaher in a report on Thursday, June 11th. They issued a “neutral” rating and a $200.00 target price for the company. Wells Fargo & Company lowered their price objective on Danaher from $212.00 to $195.00 and set an “equal weight” rating for the company in a research note on Wednesday, July 22nd. Stifel Nicolaus cut their target price on shares of Danaher from $260.00 to $220.00 and set a “buy” rating on the stock in a research report on Wednesday, July 22nd. UBS Group initiated coverage on shares of Danaher in a report on Wednesday, September 9th. They set a “buy” rating and a $250.00 price target on the stock. Finally, The Goldman Sachs Group boosted their target price on shares of Danaher from $210.00 to $250.00 and gave the company a “buy” rating in a report on Monday, September 21st. Two research analysts have rated the stock with a Strong Buy rating, seventeen have assigned a Buy rating and five have given a Hold rating to the company. According to data from MarketBeat.com, the company currently has an average rating of “Moderate Buy” and an average price target of $234.09.

Read Our Latest Stock Analysis on DHR

Danaher Trading Down 1.6%

Shares of NYSE:DHR traded down $3.48 during mid-day trading on Tuesday, hitting $217.73. The company had a trading volume of 1,774,393 shares, compared to its average volume of 4,452,227. The company has a debt-to-equity ratio of 0.48, a current ratio of 1.65 and a quick ratio of 1.25. Danaher Corporation has a one year low of $160.93 and a one year high of $242.80. The firm has a fifty day moving average price of $209.69 and a 200 day moving average price of $193.88. The company has a market capitalization of $153.06 billion, a PE ratio of 38.67, a price-to-earnings-growth ratio of 2.67 and a beta of 0.76.

Danaher (NYSE:DHR – Get Free Report) last posted its quarterly earnings results on Monday, July 20th. The conglomerate reported $1.94 EPS for the quarter, topping analysts’ consensus estimates of $1.85 by $0.09. Danaher had a net margin of 15.95% and a return on equity of 11.04%. The business had revenue of $6.26 billion during the quarter, compared to analysts’ expectations of $6.12 billion. During the same period last year, the company posted $0.77 earnings per share. The business’s quarterly revenue was up 5.5% on a year-over-year basis. As a group, research analysts forecast that Danaher Corporation will post 8.53 EPS for the current year.

Danaher Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Friday, October 30th. Investors of record on Wednesday, September 30th will be paid a dividend of $0.40 per share. This represents a $1.60 dividend on an annualized basis and a yield of 0.7%. The ex-dividend date of this dividend is Wednesday, September 30th. Danaher’s dividend payout ratio is 28.42%.

Danaher Profile

(Free Report)

Danaher Corporation (NYSE: DHR) is a global science and technology company that develops and manufactures products, services and solutions for the life sciences, diagnostics and biotechnology industries. Its offerings help researchers, healthcare professionals and biopharmaceutical manufacturers discover, develop, produce and analyze medicines and other biological products.

The company operates through businesses that provide laboratory instruments, consumables, software and services, including technologies for cell analysis, genomics, protein research, bioprocessing and clinical diagnostics.

See Also

Want to see what other hedge funds are holding DHR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Danaher Corporation (NYSE:DHR – Free Report).

Institutional Ownership by Quarter for Danaher (NYSE:DHR)

Receive News & Ratings for Danaher Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher and related companies with MarketBeat.com's FREE daily email newsletter.